3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Wilms Tumor
1
Sarcoma, Myeloid
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Retinoblastoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Hepatoblastoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Granulocyte Colony-Stimulating Factor
6
Filgrastim
6
Thiotepa
5
Etoposide
4
Cyclophosphamide
4
Carboplatin
4
Busulfan
4
Melphalan
3
Ifosfamide
3
Topotecan
2
Peripheral Blood Stem Cell Transplantation
2
Mesna
2
sargramostim
1
racotumomab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
etoposide phosphate
1
cixutumumab
1
becatecarin
1
alvocidib
1
abemaciclib
1
Vincristine
1
Ursodeoxycholic Acid
1
Thrombopoietin
1
Thalidomide
1
Temozolomide
1
Stem Cell Transplantation
1
Sirolimus
1
Simvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinoblastoma
×
pegylated granulocyte colony-stimulating factor
×
Sarcoma
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled